[논문] Anti-cancer effects of YAP inhibitor (CA3) in combination with sorafenib against hepatocellular carcinoma (HCC) in patient-derived multicellular tumor spheroid models(MCTS) [Cancers 2022]-epub YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation [Hepatology 2021] Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma [J Cancer Res Clin Oncol. 2021] Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion. [J Hepatocell Carcinoma. 2020]-epub Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma. [Clin Mol Hepatol. 2020] Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer. [J Gastroenterol Hepatol. 2017] Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis. [Hepatol Int. 2017] Endoscopic Management of Gastrointestinal Leaks and Perforation with Polyglycolic Acid Sheets. [Clin Endosc. 2017]